NCT01744249 2021-02-02Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine CarcinomasGrupo Espanol de Tumores NeuroendocrinosPhase 2/3 Unknown255 enrolled